35.10p-2.40 (-6.40%)26 Feb 2024, 10:34
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Sareum Holdings PLC Market & Company News

15.02.2024 11:20SARSareum hails safety profile for SDC-1801 after phase 1 trialAlliance
15.02.2024 10:52DSW, SAR, N4PAIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A marketsAlliance
15.02.2024 07:00SARUpdate on SDC-1801 Clinical Trial ProgressRNS
02.01.2024 10:05POS, SAR, LLAIAIM WINNERS & LOSERS: LungLife AI soars on test; Plexus falls on dealAlliance
02.01.2024 09:31SARSareum soars as partner agrees SRA737 licence with US biopharma firmAlliance
02.01.2024 07:00SARDevelopment and commercialisation licence SRA737RNS
14.12.2023 20:20CTL, DGI9, AWEMEARNINGS AND TRADING: CleanTech raises GBP520,000 in open offerAlliance
14.12.2023 15:35SARResults of AGMRNS
14.12.2023 07:00SARAnnual General Meeting StatementRNS
07.12.2023 14:31SAR, MVI, HE1UK shareholder meetings calendar - next 7 daysAlliance
23.11.2023 14:28RGO, SARIN BRIEF: Sareum Holdings draws down on equity prepayment facilityAlliance
23.11.2023 07:00SARDrawdown of Equity Prepayment FacilityRNS
21.11.2023 07:00SARNotice of AGM, Annual Report and AccountsRNS
09.11.2023 13:47UOG, SAR, CNCEARNINGS AND TRADING: MetalNRG hails Gold Ridge findingsAlliance
09.11.2023 07:00SARInitiation of food effects study for SDC-1801RNS
08.11.2023 15:03SARDirector DealingsRNS
03.11.2023 09:01SAR Sareum says patent notice in Japan boosts confidence in SDC-1801Alliance
03.11.2023 07:05SARSareum enhances SDC-1801 patent protectionRNS
02.11.2023 14:48SARExercise of Share Options and Director DealingsRNS
09.10.2023 10:58SARSareum says earnings down but product development going wellAlliance
09.10.2023 07:00SARFinal Results for the Year Ended 30 June 2023RNS
03.10.2023 07:00SARNotice of Results and Investor PresentationRNS
06.09.2023 07:00SARDirector's DealingRNS
05.09.2023 07:00SARDirector DealingRNS
04.09.2023 09:18SARSareum begins dosing participants in phase 1a trial for SDC-1801Alliance
04.09.2023 07:00SARDosing of first subjects in MAD Phase 1a trialRNS
16.08.2023 13:13SARSareum flagship drug trial progressing well ahead of annual resultsAlliance
16.08.2023 07:00SARUpdate on financial and operational progressRNS
03.08.2023 14:16SARIN BRIEF: Sareum secures GBP5 million of funding from RiverFort GlobalAlliance
03.08.2023 07:00SAREquity Prepayment Facility of up to £5 millionRNS
26.06.2023 17:33SAR, CHF, CNETRADING UPDATES: New patents for Sareum; Guanajuato hails assessmentAlliance
26.06.2023 07:00SARSareum Announces Two New Granted PatentsRNS
06.06.2023 13:36SARIN BRIEF: Sareum doses first subjects in psoriasis drug trialAlliance
06.06.2023 07:00SARDosing commences in Phase 1a trial of SDC-801RNS
18.05.2023 14:31ARV, STB, CICTRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effectAlliance
18.05.2023 07:00SARPhase 1a clinical trial for SDC-1801RNS
05.05.2023 11:26SARSareum receives Australian approval for psoriasis drug clinical trialAlliance
05.05.2023 11:11BMN, APTA, SARAIM WINNERS & LOSERS: Aptamer says struggling to convert pipelineAlliance
05.05.2023 09:20SARApproval to initiate Phase 1 clinical trialRNS
22.03.2023 11:47SARSareum Holdings interim loss widens as touts psoriasis candidate drugAlliance
22.03.2023 07:00SARHalf-Year ReportRNS
17.03.2023 18:06SARIN BRIEF: Sareum makes trial application for SDC-1801 in AustraliaAlliance
15.03.2023 15:43VTY, TRB, SARUK earnings, trading statements calendar - next 7 daysAlliance
15.03.2023 07:01SARUpdate on SDC-1801RNS
15.03.2023 07:00SARNotice of Half-Year ResultsRNS
06.03.2023 11:19GSK, SARSareum says GSK's Sierra returns clinical study reports to CRT PioneerAlliance
06.03.2023 07:00SARUpdate on SRA737RNS
29.12.2022 15:14SARDirector/PDMR ShareholdingRNS
16.12.2022 21:53BCE, KAV, CMHTRADING UPDATES: Dev Clever to cancel shares; Tintra raises fundsAlliance
16.12.2022 15:29SARResults of AGMRNS
16.12.2022 10:44SAR, TIMEAIM WINNERS & LOSERS: Time Finance jumps on strong first-half resultsAlliance
16.12.2022 07:00SARAGM StatementRNS
09.12.2022 15:43THX, SAR, JGGIUK shareholder meetings calendar - next 7 daysAlliance
24.11.2022 07:00SARNotice of AGM, Annual Report and AccountsRNS
21.11.2022 12:44SARIN BRIEF: Sareum salutes publication of SRA737 combination trial dataAlliance
21.11.2022 07:00SARSareum notes publication of SRA737 clinical dataReach
09.11.2022 16:41SARSecond Price Monitoring ExtnRNS
09.11.2022 16:35SARPrice Monitoring ExtensionRNS
09.11.2022 14:05SARSecond Price Monitoring ExtnRNS
09.11.2022 14:00SARPrice Monitoring ExtensionRNS
09.11.2022 11:05SARSecond Price Monitoring ExtnRNS
09.11.2022 11:00SARPrice Monitoring ExtensionRNS
09.11.2022 09:05SARSecond Price Monitoring ExtnRNS
09.11.2022 09:00SARPrice Monitoring ExtensionRNS
08.11.2022 17:23SARUpdate on SDC-1801 CTA ApplicationRNS
24.10.2022 10:28GSK, SARIN BRIEF: Sareum widens annual loss; considers future of SRA737Alliance
24.10.2022 07:00SARFinal Results for the Year Ended 30 June 2022RNS
12.10.2022 10:47SAR, GSKSareum plunges as GSK subsidiary Sierra returns rights for SRA737Alliance
12.10.2022 07:00SARUpdate on SRA737RNS
30.09.2022 16:41SARSecond Price Monitoring ExtnRNS
30.09.2022 16:36SARPrice Monitoring ExtensionRNS
13.09.2022 08:13SARCORRECT: Sareum notes US FDA approval of Bristol-Myers's SotyktuAlliance
12.09.2022 12:27SARSareum receives US US Food & Drug Administration approval for SotyktuAlliance
12.09.2022 07:00SARSareum notes FDA approval of first TYK2 InhibitorReach
28.07.2022 07:00SARCTA application to MHRA and Corporate UpdateRNS
Showing 1 to 75 of 165